Engineers Gate Manager LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1620220 NEW YORK, NY

Position in TBPH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,837,576

+$1,070,317 QoQ

Shares Held

113,221

+176.1% QoQ

Ownership

0.220%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Engineers Gate Manager LP holds $231,424,988 across 145 Biotechnology names. TBPH ranks #24 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	158,792	$25,965,667
2	BMRN	Biomarin Pharmaceutical Inc	436,860	$24,678,221
3	BBIO	BridgeBio Pharma, Inc.	243,729	$18,099,315
4	JAZZ	Jazz Pharmaceuticals plc	92,990	$17,579,759
5	ALNY	Alnylam Pharmaceuticals, Inc.	32,502	$10,753,936
6	IONS	Ionis Pharmaceuticals Inc	133,827	$10,049,069
7	TVTX	Travere Therapeutics, Inc.	254,401	$7,558,253
8	ROIV	Roivant Sciences Ltd.	256,447	$7,103,581

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,837,576	113,221	+176.1%	Shares	Sole	2026-05-15
2025-12-31	$767,259	41,008	+84.0%	Shares	Sole	2026-02-17
2025-09-30	$325,361	22,285	+63.2%	Shares	Sole	2025-11-14
2025-06-30	$150,636	13,657	-31.1%	Shares	Sole	2025-08-14
2024-12-31	$186,619	19,832	-26.6%	Shares	Sole	2025-02-14
2024-09-30	$217,821	27,025	+38.8%	Shares	Sole	2024-11-14
2024-06-30	$165,164	19,477	+63.4%	Shares	Sole	2024-08-14
2024-03-31	$106,931	11,921	-52.3%	Shares	Sole	2024-05-15
2023-12-31	$280,763	24,979	+35.2%	Shares	Sole	2024-02-14
2021-09-30	$136,766	18,482	+2.4%	Shares	Sole	2021-11-15
2020-12-31	$320,766	18,051	-75.5%	Shares	Sole	2021-02-16
2020-06-30	$1,546,270	73,667	+81.4%	Shares	Sole	2020-08-17
2020-03-31	$938,751	40,621	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.